| |
| |
|
| Insider
Information: |
Bradsher Neal C |
| Relationship: |
10% Owner |
| City: |
Union City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
129,185 |
|
|
Indirect Shares
|
57,363,752 |
|
|
| Direct
Value |
$1,156,585 |
|
|
|
Indirect Value
|
$486,514,725 |
|
|
| Total
Shares |
57,492,937 |
|
|
| Total
Value |
$487,671,310 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
60
|
50
|
|
Stock
price went up :
|
36
|
16
|
| Stock
price went down : |
24
|
34
|
| |
|
|
|
Gain/Loss Ratio : |
1.5
|
1.5
|
| Percentage
Gain/Loss : |
 6.9%
|
 -929.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Questcor Pharmaceuticals Inc |
QCOR |
Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director, 10% Owner |
2024-02-06 |
87,628 |
2024-02-06 |
41,666,255 |
Premium* |
|
|
Comarco Inc |
CMRO |
10% Owner |
2017-09-15 |
15,500 |
2017-09-15 |
0 |
Premium* |
|
|
STAAR Surgical Co |
STAA |
10% Owner |
2024-05-09 |
25,900 |
2024-05-09 |
10,768,431 |
Premium* |
|
|
Palomar Medical Technologies Inc |
PMTI |
10% Owner |
2013-06-24 |
0 |
2013-06-24 |
0 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
See Remarks Below |
2019-03-08 |
0 |
2019-03-08 |
0 |
Premium* |
|
|
Oncocyte Corp |
OCX |
10% Owner |
2024-04-11 |
157 |
2024-04-11 |
4,929,066 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
612 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 22 of 25
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-06-15 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
9,000,357 |
0 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-06-15 |
4 |
S |
$147.46 |
$5,217,135 |
D/D |
(35,380) |
9,000,357 |
0 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-06-16 |
4 |
S |
$148.79 |
$4,544,493 |
D/D |
(30,543) |
8,969,814 |
0 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-06-16 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
8,969,814 |
0 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-06-17 |
4 |
S |
$150.31 |
$9,604,208 |
D/D |
(63,896) |
8,905,918 |
0 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-06-17 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
8,905,918 |
0 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-06-18 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
8,892,682 |
0 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-06-18 |
4 |
S |
$152.59 |
$2,019,681 |
D/D |
(13,236) |
8,892,682 |
0 |
% |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2021-06-25 |
4 |
OE |
$2.20 |
$54,384 |
D/D |
24,720 |
87,628 |
0 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-07-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(655) |
8,663,584 |
0 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2021-07-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(0) |
8,663,584 |
0 |
- |
|
| OCX |
Oncocyte Corp |
10% Owner |
– – • |
2021-09-23 |
4 |
OE |
$0.00 |
$0 |
I/I |
0 |
17,349,945 |
0 |
- |
|
| OCX |
Oncocyte Corp |
10% Owner |
– – • |
2021-09-23 |
4 |
OE |
$3.15 |
$1,807,836 |
D/D |
573,461 |
17,349,945 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2022-03-23 |
4 |
B |
$1.37 |
$355,305 |
D/D |
260,106 |
34,265,485 |
3.92 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2022-03-23 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
34,265,485 |
2.17 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2022-03-24 |
4 |
B |
$1.42 |
$284,340 |
D/D |
200,000 |
34,465,485 |
3.92 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2022-03-24 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
34,465,485 |
2.17 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2022-03-25 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
34,935,485 |
2.17 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2022-03-25 |
4 |
B |
$1.44 |
$678,022 |
D/D |
470,000 |
34,935,485 |
3.92 |
- |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2022-12-27 |
4 |
B |
$47.91 |
$2,490,534 |
D/D |
51,985 |
8,643,992 |
2.45 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2022-12-27 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
8,643,992 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2022-12-28 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
8,743,992 |
1.42 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2022-12-28 |
4 |
B |
$46.98 |
$4,697,610 |
D/D |
100,000 |
8,743,992 |
2.45 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2022-12-29 |
4 |
B |
$47.93 |
$1,873,431 |
D/D |
39,090 |
8,783,082 |
2.45 |
% |
|
| STAA |
STAAR Surgical Co |
10% Owner |
– – • |
2022-12-29 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
8,783,082 |
1.42 |
% |
|
612 Records found
|
|
Page 22 of 25 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
